PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32125592-7	2020	NaBu treatment was also able to decrease mast cell recruitment/activation and the levels of CXCL1, CCL2, IL-6, TNF-alpha, and TGF-beta1 in the implants but did not alter the levels of IL-10.	sethoxydim	0-4	transforming growth factor, beta 1	Mus musculus	126-135	
33356962-6	2021	Moreover, NaBu was able to modulate matrix remodeling aspects of the granulation tissue such as proteoglycans production, collagen deposition and alpha-SMA expression in vivo, besides to increase TGF-b1 levels in the fibrovascular tissue, in a GPR43-dependent manner.	sethoxydim	10-14	transforming growth factor, beta 1	Mus musculus	196-202	
33356962-7	2021	Interestingly, NaBu directly stimulated L929 murine fibroblasts migration, and TGF-beta1 and collagen production in vitro.	sethoxydim	15-19	transforming growth factor, beta 1	Mus musculus	79-88	
32125592-10	2020	The circulating levels of TNF-alpha and TGF-beta1 were also attenuated by NaBu.	sethoxydim	74-78	transforming growth factor, beta 1	Mus musculus	40-49